Outcomes of hospitalized hematologic oncology patients receiving rapid response system activation for acute deterioration.

ABSTRACT:

Background

Patients with hematologic malignancies who are admitted to hospital are at increased risk of deterioration and death. Rapid response systems (RRSs) respond to hospitalized patients who clinically deteriorate. We sought to describe the characteristics and outcomes of hematologic oncology inpatients requiring rapid response system (RRS) activation, and to determine the prognostic accuracy of the SIRS and qSOFA criteria for in-hospital mortality of hematologic oncology patients with suspected infection.

Methods

We used registry data from two hospitals within The Ottawa Hospital network, between 2012 and 2016. Consecutive hematologic oncology inpatients who experienced activation of the RRS were included in the study. Data was gathered at the time of RRS activation an

SUBMITTER: Gershkovich B 

PROVIDER: S-EPMC6712869 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature